OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine
Bikash Sahay, Janet K. Yamamoto
Viruses (2018) Vol. 10, Iss. 5, pp. 277-277
Open Access | Times Cited: 13
Bikash Sahay, Janet K. Yamamoto
Viruses (2018) Vol. 10, Iss. 5, pp. 277-277
Open Access | Times Cited: 13
Showing 13 citing articles:
Risk factors and clinical and laboratory findings associated with feline immunodeficiency virus and feline leukemia virus infections in Bangkok, Thailand
Oumaporn Rungsuriyawiboon, Thitichai Jarudecha, Supa Hannongbua, et al.
Veterinary World (2022), pp. 1601-1609
Open Access | Times Cited: 12
Oumaporn Rungsuriyawiboon, Thitichai Jarudecha, Supa Hannongbua, et al.
Veterinary World (2022), pp. 1601-1609
Open Access | Times Cited: 12
Prevalence of feline leukaemia virus and feline immunodeficiency virus in domestic cats in Ireland
Anna Szilasi, Lilla Dénes, Eszter Krikó, et al.
Acta Veterinaria Hungarica (2021) Vol. 68, Iss. 4, pp. 413-420
Open Access | Times Cited: 14
Anna Szilasi, Lilla Dénes, Eszter Krikó, et al.
Acta Veterinaria Hungarica (2021) Vol. 68, Iss. 4, pp. 413-420
Open Access | Times Cited: 14
Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses
Bikash Sahay, Alek M. Aranyos, Meerambika Mishra, et al.
Viruses (2019) Vol. 11, Iss. 2, pp. 136-136
Open Access | Times Cited: 8
Bikash Sahay, Alek M. Aranyos, Meerambika Mishra, et al.
Viruses (2019) Vol. 11, Iss. 2, pp. 136-136
Open Access | Times Cited: 8
Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax® FIV)
Mark Westman, Dennis Yang, Jennifer Green, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 470-470
Open Access | Times Cited: 6
Mark Westman, Dennis Yang, Jennifer Green, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 470-470
Open Access | Times Cited: 6
Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector
Xinru Luo, Ruiying Liang, Lin Liang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Xinru Luo, Ruiying Liang, Lin Liang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs
Tiffany A. Peterson, Andrew G. MacLean
Journal of Neuroimmune Pharmacology (2018) Vol. 14, Iss. 1, pp. 68-93
Open Access | Times Cited: 4
Tiffany A. Peterson, Andrew G. MacLean
Journal of Neuroimmune Pharmacology (2018) Vol. 14, Iss. 1, pp. 68-93
Open Access | Times Cited: 4
Shell disorder and the HIV vaccine mystery: lessons from the legendary Oswald Avery
Gerard Kian‐Meng Goh, Vladimir N. Uversky
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 12, pp. 5702-5711
Closed Access | Times Cited: 4
Gerard Kian‐Meng Goh, Vladimir N. Uversky
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 12, pp. 5702-5711
Closed Access | Times Cited: 4
Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax® Lv-K and Fel-O-Vax® 5)
Mark Westman, Jacqueline M. Norris, Richard Malík, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 240-240
Open Access | Times Cited: 4
Mark Westman, Jacqueline M. Norris, Richard Malík, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 240-240
Open Access | Times Cited: 4
Identification of a Potential Inhibitor of the FIV p24 Capsid Protein and Characterization of Its Binding Site
Mathieu Long, François‐Xavier Cantrelle, Xavier Robert, et al.
Biochemistry (2021) Vol. 60, Iss. 24, pp. 1896-1908
Open Access | Times Cited: 4
Mathieu Long, François‐Xavier Cantrelle, Xavier Robert, et al.
Biochemistry (2021) Vol. 60, Iss. 24, pp. 1896-1908
Open Access | Times Cited: 4
Leveraging Data from Spontaneous Animal Disease Models to Streamline Pharmaceutical Research: A Tale of Two Species
Jonathan P. Mochel, Karin Allenspach
(2023)
Open Access | Times Cited: 1
Jonathan P. Mochel, Karin Allenspach
(2023)
Open Access | Times Cited: 1
Developing a Feline Immunodeficiency Virus Subtype B Vaccine Prototype Using a Recombinant MVA Vector
Luis Adan Flores Andrade, Alice F. Versiani, Edel Figueiredo Barbosa‐Stancioli, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1717-1717
Open Access | Times Cited: 2
Luis Adan Flores Andrade, Alice F. Versiani, Edel Figueiredo Barbosa‐Stancioli, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1717-1717
Open Access | Times Cited: 2
Utilizing FIV (Feline Immunodeficiency Virus) to develop a novel animal model to study HIV (Human Immunodeficiency Virus)
Ankita Kambli
(2019)
Closed Access
Ankita Kambli
(2019)
Closed Access
Feline Immunodeficiency Virus
Tom R. Phillips
Clinical Small Animal Internal Medicine (2020), pp. 883-885
Closed Access
Tom R. Phillips
Clinical Small Animal Internal Medicine (2020), pp. 883-885
Closed Access
